| Dr Gregory James Crane, MD | |
|
12200 W 110th St, Overland Park, KS 66210-4045 | |
| (913) 574-2650 | |
| (913) 574-2769 |
| Full Name | Dr Gregory James Crane |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 17 Years |
| Location | 12200 W 110th St, Overland Park, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225299126 | NPI | - | NPPES |
| 1225299126 | Medicaid | MO | |
| 201082060A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 2013015478 (Missouri) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 0436502 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Kansas Hospital Authority | 9436054798 | 250 |
News Archive
A new study showed that the proportion of young people admitting to having had unprotected sex with a new partner has risen over the past two years.
The Hearing Loss Clinic, today announced plans for the eight day hearing mission trip to Mombasa, Kisumu, and Nairobi, Kenya projected to result in fitting more than 3,000 adults and children receiving over 6,000 hearing instruments.
RESEARCHERS have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to guide treatments to the cancer, according to new research presented at the National Cancer Research Institute Cancer Conference in Liverpool.
Medical device company Vertos Medical, Inc., developer of the mild® procedure for lumbar spinal stenosis (LSS), today announced it has completed a $15.5 million Series D financing. New investor, ONSET Ventures, led the round with additional participation from existing Vertos investors CHL Medical Partners, Foundation Medical Partners, Aweida Venture Partners and DFJ Mercury.
Drug resistance remains a major problem in combating HIV infection, but a different approach to drug development could be the answer.Current viral inhibitors target the HIV-1 protease function with a competitive mechanism. Writing in the BJ ChemBio Knowledge Environment of the Biochemical Journal, Max Chang and colleagues from the Scripps Research Institute, La Jolla, suggest that pharmaceutical companies look at compounds that use an allosteric non-competitive mechanism of inhibition.
› Verified 7 days ago
| Entity Name | University Of Kansas Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528019502 PECOS PAC ID: 9436054798 Enrollment ID: O20050908001103 |
News Archive
A new study showed that the proportion of young people admitting to having had unprotected sex with a new partner has risen over the past two years.
The Hearing Loss Clinic, today announced plans for the eight day hearing mission trip to Mombasa, Kisumu, and Nairobi, Kenya projected to result in fitting more than 3,000 adults and children receiving over 6,000 hearing instruments.
RESEARCHERS have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to guide treatments to the cancer, according to new research presented at the National Cancer Research Institute Cancer Conference in Liverpool.
Medical device company Vertos Medical, Inc., developer of the mild® procedure for lumbar spinal stenosis (LSS), today announced it has completed a $15.5 million Series D financing. New investor, ONSET Ventures, led the round with additional participation from existing Vertos investors CHL Medical Partners, Foundation Medical Partners, Aweida Venture Partners and DFJ Mercury.
Drug resistance remains a major problem in combating HIV infection, but a different approach to drug development could be the answer.Current viral inhibitors target the HIV-1 protease function with a competitive mechanism. Writing in the BJ ChemBio Knowledge Environment of the Biochemical Journal, Max Chang and colleagues from the Scripps Research Institute, La Jolla, suggest that pharmaceutical companies look at compounds that use an allosteric non-competitive mechanism of inhibition.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory James Crane, MD 12200 W 110th St, Overland Park, KS 66210-4045 Ph: (913) 574-2650 | Dr Gregory James Crane, MD 12200 W 110th St, Overland Park, KS 66210-4045 Ph: (913) 574-2650 |
News Archive
A new study showed that the proportion of young people admitting to having had unprotected sex with a new partner has risen over the past two years.
The Hearing Loss Clinic, today announced plans for the eight day hearing mission trip to Mombasa, Kisumu, and Nairobi, Kenya projected to result in fitting more than 3,000 adults and children receiving over 6,000 hearing instruments.
RESEARCHERS have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to guide treatments to the cancer, according to new research presented at the National Cancer Research Institute Cancer Conference in Liverpool.
Medical device company Vertos Medical, Inc., developer of the mild® procedure for lumbar spinal stenosis (LSS), today announced it has completed a $15.5 million Series D financing. New investor, ONSET Ventures, led the round with additional participation from existing Vertos investors CHL Medical Partners, Foundation Medical Partners, Aweida Venture Partners and DFJ Mercury.
Drug resistance remains a major problem in combating HIV infection, but a different approach to drug development could be the answer.Current viral inhibitors target the HIV-1 protease function with a competitive mechanism. Writing in the BJ ChemBio Knowledge Environment of the Biochemical Journal, Max Chang and colleagues from the Scripps Research Institute, La Jolla, suggest that pharmaceutical companies look at compounds that use an allosteric non-competitive mechanism of inhibition.
› Verified 7 days ago
Dr. Matthew P Harrison, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 10116 W 105th St, Overland Park, KS 66212 Phone: 913-541-0510 Fax: 913-541-1852 | |
Louay K. Sabih, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 10550 Marty St Ste 201, Overland Park, KS 66212 Phone: 913-341-4000 Fax: 913-383-2868 | |
Kimberly Foley Nagel, ARNP Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5701 W 119th St, Suite 345, Overland Park, KS 66209 Phone: 913-339-9046 Fax: 913-339-9018 | |
Dr. Paul G Diederich, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 10787 Nall Ave, Ste. 310, Overland Park, KS 66211 Phone: 913-945-6900 Fax: 913-945-6970 | |
Mini R Abraham, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 10000 College Blvd, Overland Park, KS 66210 Phone: 913-258-5055 Fax: 913-258-5057 | |
Jeena Viji Eapen, M.D. Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 10540 Marty St Ste 100, Overland Park, KS 66212 Phone: 913-660-1616 Fax: 913-660-0998 | |
Dr. Arnold Leslie Katz, MD Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 10550 Quivira Road, Suite 320, Overland Park, KS 66215 Phone: 913-888-3231 Fax: 913-888-7281 |